Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)
暂无分享,去创建一个
L. Martí-Bonmatí | O. Rouvière | B. Maes | F. Vrtovsnik | F. Glowacki | T. Hannedouche | L. Bacigalupo | J. Boffa | J. Ferreirós | G. Deray | P. Campioni | C. Rigothier | J. Billiouw | D. Alison | D. Devos